Physician profile
David Kim
NPI 1235517996
$1,975.01
in general payments reported to CMS, 2019-2025
13 companies · $1,601 in 2025
The $1,601 reported for 2025 was more than what 80% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $239 · 2024: $135 · 2025: $1,601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $925 · Food and Beverage: $811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $925.25 |
| Food and Beverage | $810.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,176.00 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbvie INC. | $176.07 | 2024-2025 | |
| Musculoskeletal Transplant Foundation INC. | $163.50 | 2025 | |
| Medline Industries LP | $143.84 | 2022 | |
| Axogen | $94.94 | 2022 | |
| Smith+Nephew, INC. | $45.28 | 2025 | Stravix, Collagenase Santyl |
| Vertex Pharmaceuticals Incorporated | $32.81 | 2025 | |
| Davol INC. | $32.12 | 2025 | Phasix Mesh |
| Tela Bio, INC. | $27.46 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $26.81 | 2025 | Transorb |
| Solventum Corporation | $21.12 | 2025 | Prevena, V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice |
| Urgo Medical North America, LLC | $20.16 | 2025 | Urgoclean Ag |
| Tactile Systems Technology INC | $14.90 | 2024 | Flexitouch Plus, Entre Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.